AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 123 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 68,800 | -22.6% | 0.00% | – |
| Q2 2022 | $1,000 | -80.0% | 88,900 | +68.4% | 0.00% | – |
| Q1 2022 | $5,000 | +150.0% | 52,800 | +259.2% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 14,700 | -28.3% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 20,500 | +7.9% | 0.00% | – |
| Q2 2021 | $1,000 | -90.9% | 19,000 | -54.2% | 0.00% | – |
| Q1 2021 | $11,000 | -71.8% | 41,500 | -61.8% | 0.00% | -100.0% |
| Q4 2020 | $39,000 | +225.0% | 108,600 | +102.2% | 0.00% | – |
| Q3 2020 | $12,000 | +20.0% | 53,700 | +25.2% | 0.00% | -100.0% |
| Q2 2020 | $10,000 | +11.1% | 42,900 | -19.2% | 0.00% | 0.0% |
| Q1 2020 | $9,000 | +12.5% | 53,100 | +30.8% | 0.00% | – |
| Q4 2019 | $8,000 | -99.4% | 40,600 | -77.4% | 0.00% | -100.0% |
| Q3 2013 | $1,346,000 | +68.9% | 179,402 | +29.9% | 0.04% | +59.3% |
| Q2 2013 | $797,000 | – | 138,102 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVA Family Office, LLC | 1,173,200 | $1,865,000 | 1.14% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $1,387,000 | 0.82% |
| Cypress Capital Management LLC (WY) | 214,575 | $341,000 | 0.30% |
| Western Wealth Management, LLC | 982,350 | $1,562,000 | 0.23% |
| SRS Capital Advisors, Inc. | 615,659 | $979,000 | 0.14% |
| Willis Investment Counsel | 1,213,053 | $1,929,000 | 0.13% |
| Harvest Investment Services, LLC | 124,423 | $197,000 | 0.10% |
| Transform Wealth, LLC | 205,481 | $327,000 | 0.07% |
| COURIER CAPITAL LLC | 379,973 | $604,000 | 0.07% |
| BRIGHTON JONES LLC | 398,912 | $634,000 | 0.04% |